HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents. - sprookjes - yvandenbroek - TriplyDB

HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.

HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.

http://www.wikidata.org/entity/Q40806698

about

Hepatitis C virus - associated B cell non-Hodgkin's lymphoma Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy.Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma.Extrahepatic manifestations of HCV: the role of direct acting antivirals.Why do I treat my patients with mild hepatitis C?Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents.Antiviral therapies for managing viral hepatitis in lymphoma patients.Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma.Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C.Extrahepatic cancers and chronic HCV infection.HCV load as a possible prognostic factor in patients with HCV-related DLBCL.

P2860

Q26741172-F59E0F49-CF0E-463C-B4C4-44A88823A594 Q28080160-6F0D393E-7162-4943-9905-7E1A2DC18A77 Q37345267-0DA018D0-F99B-43C2-8ABE-A1BE1154ED7C Q38602682-4088A8C4-385A-4C5F-AD17-CFA3F94E3415 Q38676280-4B459B33-BCB3-4889-B47F-52FA426B771C Q38684508-B4BD8439-CB03-4164-A194-F788E187FC89 Q38685564-1ADB3B6D-5998-4A09-8EB7-1CB12400B926 Q38712605-F719A7F4-D41C-4BD1-B246-D81C69480896 Q38989625-2CA8E034-C6CC-4B91-9E49-E3477A6107DE Q39449570-6F0D2685-1488-4EA4-A66E-4B6A99B540DF Q40528517-22AE0316-0779-4D33-A24F-5DE5E8C19759 Q40774061-71EF066D-41F4-42ED-A434-8A2FEA7C49DA Q42921960-6B0E2E80-D1B7-4BA2-8365-5972F5515E0D Q47552769-8426C89F-615E-4885-9CB6-45318E7C236C Q49788028-66C1AC06-1C20-49A4-8549-EB8E4E885BD7

P2860

HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.

http://www.wikidata.org/entity/Q40806698

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.

@en

type

label

HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.

@en

prefLabel

HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.

@en

P1433

Q40806698-A064CCC8-3F52-4617-A3B4-A5AE16F434B8

P1476

Q40806698-0316419C-884B-406C-8E9A-B6F80B8C2FD5

P2093

Q40806698-172D0856-2232-4102-9CF3-CC2EE8EE2802

Q40806698-1B7492BE-3E1A-4A43-85E1-6D9B6F84CE9D

Q40806698-226B4C04-48F7-448E-98CB-00ACBE017C0F

Q40806698-62CF6239-E248-4728-A5F8-5987DA070528

Q40806698-6FD35EE0-23A9-407D-A94C-76FDF7AB2C13

Q40806698-B487006C-E5C4-4957-9FB5-0E1B42799F8A

Q40806698-D4A783D2-CB39-4B9A-8F81-D6200CCB778B

Q40806698-DD25164E-E928-4D79-BCC0-ABEF63B3FF5E

Q40806698-F64923A2-57D6-4147-89B6-7F9EC9E36318

P2860

Q40806698-0A0C653B-F346-4EF4-A5AB-24EB020180D2

Q40806698-2EC5843A-B21B-4DFA-B973-FB907B5BCA51

Q40806698-307DA359-5653-4DDD-B907-4127CA494CE0

Q40806698-4F59D4D8-EC9F-4A2A-A078-5BFAF49A94AD

Q40806698-54F1FE7C-6C84-4CEF-AEE1-33FD7858E0CB

Q40806698-60A96565-68BE-407D-B0A8-2A0BB5D9D241

Q40806698-6BEB98AF-E2FF-4E13-946C-AF5C79CBA92B

Q40806698-6BEDF756-50EE-4C3E-87BF-652BC8106F1E

Q40806698-8B71DD83-284F-4728-8BF1-7844EAC64BA1

Q40806698-9086ECA7-7834-42AE-99E1-B16065AD77FA

P304

Q40806698-FB7236C4-5110-495D-A400-23D2C7C8867B

P31

Q40806698-C4FE7D63-6ABF-4B8B-86D8-A7B60DB79E83

P356

Q40806698-EF08B200-E28E-4D1B-B5DC-93F58DE6C58F

P433

Q40806698-63A385A8-A7EA-4CB9-94D9-782E792C72F8

P478

Q40806698-F47897CA-C4A9-4E77-A1D1-7AA1A9B0CBF3

P50

Q40806698-567C39BF-5EA3-4B95-ACEF-14BE296F8F31

Q40806698-B9829749-BAD4-470E-BB3A-6D0F68DE0E71

Q40806698-FA6868B5-16C1-413F-9413-6913F0B42C78

P577

Q40806698-D0033B60-6623-4F39-81D4-D9E52D3CB71A

P698

Q40806698-F6638441-858E-4EF5-B5D4-8939AF3EEC26

P356

P1433

Liver International

P1476

HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.

@en

P2093

Denis Sautereau

http://www.w3.org/2001/XMLSchema#string

Julie Abraham

http://www.w3.org/2001/XMLSchema#string

Laura Mesturoux

http://www.w3.org/2001/XMLSchema#string

Marilyne Debette-Gratien

http://www.w3.org/2001/XMLSchema#string

Paul Carrier

http://www.w3.org/2001/XMLSchema#string

Pierre Marquet

http://www.w3.org/2001/XMLSchema#string

Sophie Alain

http://www.w3.org/2001/XMLSchema#string

Tessa Tabouret

http://www.w3.org/2001/XMLSchema#string

Véronique Loustaud-Ratti

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management

Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.

Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis.

HCV-related autoimmune and neoplastic disorders: the HCV syndrome.

Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes.

Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.

Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection.

Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3/NS4A inhibitor-based treatment. A case report.

Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy.

P304

2222-2227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LIV.12897

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Jérémie Jacques

P577

2015-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26104059

http://www.w3.org/2001/XMLSchema#string